Tuberculosis testing reagents
Ended Awarded Last action
- Contract number
- 36C26225N0262
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $888,466
Award facts
- Contract value 32% obligated
- $2,778,776.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $216,941 | |
| Original award | $671,525 |
About this award
Qiagen, LLC was awarded a $2.78M Blanket Purchase Agreement (BPA) call for tuberculosis testing reagents under Veterans Integrated Service Network 22 (VISN 22), a component of the Department of Veterans Affairs. The contract carries a firm fixed price structure with no set-aside designation, reflecting Qiagen's competitive standing in the open federal marketplace. The ultimate completion date is December 9, 2025, with performance taking place at Qiagen's facility in Germantown, Maryland. This award represents a call against an existing $2.56M BPA vehicle that Qiagen maintains with VISN 22 for tuberculosis testing reagents, enabling the VA to efficiently procure critical diagnostic testing supplies to support veteran healthcare initiatives.
Qiagen is a foreign-owned molecular diagnostics manufacturer specializing in laboratory equipment, reagents, and bioinformatics solutions. The company maintains an extensive federal contract portfolio across multiple agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Defense, and the Federal Bureau of Investigation. Tuberculosis testing, particularly through products such as QuantiFERON TB Gold Plus, represents a key component of Qiagen's diagnostic offerings to government healthcare systems. This procurement supports the VA's ongoing commitment to providing comprehensive infectious disease screening and diagnostic services to the veteran population.
Quick answers
Who was awarded contract 36C26225N0262?
36C26225N0262 was awarded to Qiagen, LLC by Veterans Integrated Service Network 22 (Veterans Health Administration) on December 10, 2024.
How much is contract 36C26225N0262 worth?
The government has obligated $888,466 on 36C26225N0262. Its current value, with exercised options, is $2,778,776.
Is contract 36C26225N0262 an order under another contract?
Yes. 36C26225N0262 is a BPA call under 36C26225A0011, a blanket purchase agreement.
Was contract 36C26225N0262 competed?
The extent of competition for 36C26225N0262 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award